Athos Therapeutics

About:

Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

Website: https://athostx.com/

Twitter/X: athostx

Description:

Athos Therapeutics is a late pre-clinical stage biotechnology company pioneering the development of artificial intelligence-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

Total Funding Amount:

$54.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Torrance, California, United States

Founded Date:

2019-01-01

Founders:

Allan J. Pantuck, Dimitrios Iliopoulos, Michael Jung

Number of Employees:

11-50

Last Funding Date:

2024-02-16

IPO Status:

Private

© 2024 MyAiNote.com